Proteomic Guided First-line Precision Treatment of Renal Clear Cell Carcinoma: a Single-center, Prospective, Phase II Umbrella Clinical Study
Latest Information Update: 23 Jan 2024
At a glance
- Drugs Catequentinib (Primary) ; Everolimus (Primary) ; Tislelizumab (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
Most Recent Events
- 23 Jan 2024 New trial record